EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The IGF–PAPP-A–Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer

Rikke Hjortebjerg, Claus Høgdall, Kristian Horsman Hansen, Estrid Høgdall iD, Jan Frystyk

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25042014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Rikke Hjortebjerg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center Odense, Odense University Hospital, 5000 Odense, Denmark. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Ovarian Neoplasms, Glycoproteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Arvid Nilssons Fond, The Arvid Nilssons Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pregnancy-associated plasma protein-A (PAPP-A) and PAPP-A2 modulate insulin-like growth factor (IGF) action and are inhibited by the stanniocalcins (STC1 and STC2). We previously demonstrated increased PAPP-A and IGF activity in ascites from women with ovarian carcinomas. In this prospective, longitudinal study of 107 women with ovarian cancer and ascites accumulation, we determined corresponding serum and ascites levels of IGF-1, IGF-2, PAPP-A, PAPP-A2, STC1, and STC2 and assessed their relationship with mortality. As compared to serum, we found highly increased ascites levels of PAPP-A (51-fold) and PAPP-A2 (4-fold). Elevated levels were also observed for IGF-1 (12%), STC1 (90%) and STC2 (68%). In contrast, IGF-2 was reduced by 29% in ascites. Patients were followed for a median of 38.4 months (range: 45 days to 8.9 years), during which 73 patients (68.2%) died. Overall survival was longer for patients with high serum IGF-1 (hazard ratio (HR) per doubling in protein concentration: 0.60, 95% CI: 0.40–0.90). However, patients with high ascites levels of IGF-1 showed a poorer prognosis (HR: 2.00 (1.26–3.27)). High serum and ascites IGF-2 levels were associated with increased risk of mortality (HR: 2.01 (1.22–3.30) and HR: 1.78 (1.24–2.54), respectively). Similarly, serum PAPP-A2 was associated with mortality (HR: 1.26 (1.08–1.48)). Our findings demonstrate the presence and activity of the IGF system in the local tumor ecosystem, which is likely a characteristic feature of malignant disease and plays a role in its peritoneal dissemination. The potential clinical implications are supported by our finding that serum levels of the proteins are associated with patient prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Like Growth Factor IOvarian NeoplasmsGlycoproteinsHumansFemaleInsulin-Like Growth Factor IIPregnancy-Associated Plasma Protein-AAscitesProspective StudiesEcosystemLongitudinal Studies

Stichwörter der Autor:innen

ascitesinsulin-like growth factorinsulin-like growth factor binding proteinmortalityovarian cancerpregnancy-associated plasma protein-Aprognosisstanniocalcin

Substanzen

Insulin-Like Growth Factor IteleocalcinInsulin-Like Growth Factor IIPregnancy-Associated Plasma Protein-AGlycoproteins

Autor:innen und Institutionen

  • Steno Diabetes Center Odense, Odense University Hospital, 5000 Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, 5230 Odense, Denmark.
  • Department of Gynecology, Juliane Marie Center, Rigshospitalet, 2100 Copenhagen, Denmark.
  • Endocrine Research Unit, Department of Endocrinology, Odense University Hospital, 5000 Odense, Denmark.
  • OPEN Lab, Odense University Hospital, 5000 Odense, Denmark.
  • Department of Pathology, Herlev University Hospital, 2730 Herlev, Denmark.

ORCID-Profile: Estrid Høgdall

Förderung

  • Arvid Nilssons Fond
  • The Arvid Nilssons Foundation

Zitieren

APA

Hjortebjerg, R., Høgdall, C., Hansen, K. H., Høgdall, E., & Frystyk, J. (2024). The IGF–PAPP-A–Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25042014

Vancouver

Hjortebjerg R, Høgdall C, Hansen KH, Høgdall E, Frystyk J. The IGF–PAPP-A–Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25042014

BibTeX
@article{Hjortebjerg2024,
  author = {Hjortebjerg, Rikke and Høgdall, Claus and Hansen, Kristian Horsman and Høgdall, Estrid and Frystyk, Jan},
  title = {The IGF–PAPP-A–Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25042014}
}
Kostenlos starten →